There was no significant difference in the levels of USP9x transcripts in ccRCC tumor samples comparing metastatic and non-metastatic disease or comparing low- vs high-grade tumors, but USP9x transcript levels were slightly lower in advanced vs early stage samples in the KIRC data set (Supplementary Figure S7). The gene discussed is USP9X; the disease is metastatic neoplasm.